...J Clin. Invest., 1993 (in press). 122. Galloway, JA, Hooper, SA, Spradin, CT, Howey, DC, Frank. BH, et al., Biosynthetic human proinsulin: review of chemistry, in vitro and in vivo receptor binding, arterial and human pharmacology, and clinical experience, Diabetes Care. 15, 666, 1992. 123. Riccio,...

...Peptide Symposium. Pierce Chemical Company. Rockford. pp. 729-738. 25. Galloway. JA et al. (1992). Biosynthetic human proinsulin. Review of chemistry,...studies, and clinical trial experience. Diabetes Care, 15(5), 666-692 26 DiMarchi, R. et al. (1989) Synthesis of insulin-like growth factor I through recombinant...

...52:927—932,1948. 102. Galloway JA, Hooper SA, Spradlin CT, Howey DC, Frank BH, Bowsher RB., and Anderson JH: Biosynthetic Human Proinsulin: Review of chemistry,...binding, animal and human pharmacology studies, and dinical trial experience. Diabetes Care 15:666-692,1992. 103. Steiner, DF: The Proprotein Convertases....

...concentration in high- and lowrisk populations for NIDDM. Diabetes. 43:1490-3. 48. Galloway, iA., et a!. 1992. Biosynthetic human proinsulin. Review of chemistry,...studies, and clinical trial experience. Diabetes Care. 15:666-92. 49. Halban, PA. 1991. Structural domains and molecular lifestyles of insulin and its precursors...

...BH, Veros AJ. Interaction of zinc with proinsulin. Biochem Biophys Res Commun 1970:38:284-288. 14. Galloway JA, Hooper SA, Spradlin CT, et al. Biosynthetic human proinsulin. Review of chemistry, in wire and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience....